Drew Barrymore Sells Historic Westchester Estate After 5 Million Renovation Indian Benchmarks Hit Highest Close Since April on West Asia Developments PutinXi Talks Set to Revive LongStalled Power of Siberia 2 Pipeline Amid Energy Market Turmoil SpaceX Successfully Launches Starship on Second Attempt Advancing Reusable Rocket Development Fitness Apps Challenge Traditional Personal Training Market Implications and Investment Perspective FutureProofing Additive Manufacturing Intellectual Property Security in Decentralized Production Barnes Noble Education Inc BNED Q4 2025 Earnings NarrowerThanExpected Loss Lifts Shares Amid Structural Challenges Johnson Controls Q1 2026 Earnings EPS Surpasses Estimates Shares Rise STERIS plc STE Q1 2026 Earnings EPS Misses Estimates as Stock Dips Slightly Willis Lease Finance Corporation WLFC Q1 2026 Earnings Strong EPS Beat Driven by Asset Utilization and Leasing Demand LECO Q1 2026 Earnings Modest EPS Beat Amidst Steady Operational Performance ARB IOT Group Limited ARBB Holds Near Support as Downside Pressure Persists Pinnacle Food Group Limited PFAI Holds Near Support After Modest Pullback Matador Resources MTDR Slips 24 as Energy Sector Headwinds Mount Carlyle Credit Income Fund Series D Preferred Shares CCID Hold Steady at 2535 Kochav Defense Acquisition Corp KCHV Holds Steady at 1032 as Investors Await Catalyst Plus500 Reports 11 Quarterly Revenue Growth Reaffirms FullYear Guidance ArtsWay Manufacturing Q4 2024 Earnings Modest Profitability Sustained Amid Quiet Quarter Saul Centers Inc BFS Edges Lower Amid Quiet Trading Trane Technologies Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Performance OTIS Q1 2026 Earnings EPS Misses Estimates by 185 as Market Digests Mixed Signals BGSI Q1 2026 Earnings Earnings Slightly Miss Estimates as Stock Edges Lower flyExclusive Inc FLYX Q1 2026 Earnings EPS Surpasses Estimates Despite Sparse Revenue Disclosure NG Q1 2026 Earnings Narrower Loss Than Expected as Donlin Gold Project Progress Continues PBT Q3 2009 Earnings Royalty Income Misses Estimates Yet Stock Gains Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech